New Campath Concentration May Create Both Convenience And Confusion
This article was originally published in The Pink Sheet Daily
Genzyme/Schering AG's Campath will switch to 30 mg/mL single dose vials that do not require filtering. The Institute for Safe Medication Practices urges caution at hospitals making the switch from the 10 mg/mL ampoules and recommends use of single vial packs to prevent errors.
You may also be interested in...
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said
Pfizer will continue to support the insomnia product for up to six months.